MENU
GKOS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Glaukos (GKOS) Ownership - Who owns Glaukos?

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

Profile

Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
10.95B
P/E Ratio
N/A
Total Cash
286.23M
Projected Growth
N/A
Total Debt
102.84M
Revenue
612.84M
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
4.85
Total Debt/Equity
N/A
Revenue/Share
10.58 USD as % of share price
View a ticker or compare two or three
GKOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com
Who owns Glaukos? GKOS symbol Ownership - Tickeron.com